The Future Role of the United States in Global Health

Abstract

U.S. global health investment has focused on detection, treatment, and eradication of infectious diseases such as tuberculosis, malaria, and human immunodeficiency virus/acquired immunodeficiency syndrome, with significant results. Although efforts should be maintained and expanded to provide ongoing therapy for chronic infectious disease, there is a pressing need to meet the challenge of noncommunicable diseases, which constitute the highest burden of diseases globally. A Committee of the National Academies of Sciences, Engineering, and Medicine has made 14 recommendations that require ongoing commitments to eradication of infectious disease and increase the emphasis on chronic diseases such as cardiovascular disease. These include improving early detection and treatment, mitigating disease risk factors, shifting global health infrastructure to include management of cardiovascular disease, developing global partners and private-public ventures to meet infrastructure and funding challenges, streamlining medical product development and supply, increasing research and development capacity, and addressing gaps in global political and institutional leadership to meet the shifting challenge.

Chemical Composition, Antioxidant and Enzyme Inhibitory Properties of Different Extracts Obtained from Spent Coffee Ground and Coffee Silverskin

“…During the last century, the prevalence of some health problems is gaining much momentum worldwide. In this respect, lifestyle habits, imbalanced diet and stress are main reasons for increasing the prevalence of such diseases [ 45 , 46 , 47 , 48 ]. In this sense, according to some researchers, humanity can be considered to be in an ongoing war against these diseases, with an endeavor to find effective weapons to fight such challenges.…”

Worldwide pacemaker and defibrillator reuse: Systematic review and meta‐analysis of contemporary trials

“…There is an urgent need to pursue practical solutions to reduce the global burden of cardiovascular disease which is foremost of the chronic illnesses that have supplanted infectious diseases as the leading cause of death in most low‐ and middle‐income nations . An estimated 1.7 million cardiac rhythm device implantations are undertaken worldwide each year .…”

US opioid prescribing: the federal government advisers with recent ties to big pharma

“…For example, a 2017 article Dzau coauthored in the Journal of the American College of Cardiology examined recommendations from a NASEM panel, co-sponsored by Medtronic 43. The article favorably mentioned Medtronic twice; Dzau, a cardiologist, made no disclosures 11…”

“…After inquiries from The BMJ Dzau published a letter of clarification about his financial interests in JAMA ,7 and the journal corrected two articles Dzau wrote about the academies’ opioids work, disclosing his ties to Medtronic 89. New financial disclosures have been or will be added to at least three other articles by Dzau on different topics, The BMJ has learnt, including in JAMA , the Journal of the American College of Cardiology , and The BMJ 101112…”